Search research articles
Contact Us
Filters
Showing results (51-60 of 90) with videos related to
Page
of 9
Sort By:
Frontiers in Cell and Developmental Biology
|
October 17, 2022
Spontaneous transitions between amoeboid and keratocyte-like modes of migration
Ted Moldenhawer, Eduardo Moreno, Daniel Schindler, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
July 27, 2025
Predicting Residual 21-Hydroxylase Enzymatic Activity in Pediatric and Adult Congenital Adrenal Hyperplasia Patients: Towards Individualized Therapy
Davide Bindellini, Robin Michelet, Yersultan Mirasbekov, et al.
Clinical Pharmacokinetics
|
August 2, 2017
Predicting Cortisol Exposure from Paediatric Hydrocortisone Formulation Using a Semi-Mechanistic Pharmacokinetic Model Established in Healthy Adults
Johanna Melin, Zinnia P Parra-Guillen, Niklas Hartung, et al.
The AAPS Journal
|
October 15, 2016
Magnitude of Increased Infliximab Clearance Imposed by Anti-infliximab Antibodies in Crohn's Disease Is Determined by Their Concentration
Helena Edlund, Casper Steenholdt, Mark A Ainsworth, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 14, 2020
Pharmacokinetic/Pharmacodynamic Evaluation of Hydrocortisone Therapy in Pediatric Patients with Congenital Adrenal Hyperplasia
Johanna Melin, Zinnia P Parra-Guillen, Robin Michelet, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
July 7, 2026
Optimizing Clinical Study Designs for CAR-T Cell Therapy: Development of an Efficient Sampling Strategy Through Optimal Experimental Design
Fenja Klima, Anna M Mc Laughlin, Robin Michelet, et al.
Pharmaceutical Statistics
|
April 2, 2019
Comment on Jaki et al., A proposal for a new PhD level curriculum on quantitative methods for drug development. Pharmaceutical Statistics 17 (5):593-606, Sep/Oct 2018, DOI: 10.1002/pst.1873
Andreas Krause, Charlotte Kloft, Wilhelm Huisinga, et al.
The Journal of Antimicrobial Chemotherapy
|
November 13, 2025
The β-lactamase inhibitor concentration-dependent minimum inhibitory concentration (MICcBLI) as methodology to assess the pharmacokinetic/pharmacodynamic relationship of piperacillin/tazobactam for dosing optimization
Malin Andersson, Franz Weber, Ferdinand Weinelt, et al.
Frontiers in Pharmacology
|
April 4, 2022
Exploring Dried Blood Spot Cortisol Concentrations as an Alternative for Monitoring Pediatric Adrenal Insufficiency Patients: A Model-Based Analysis
Viktoria Stachanow, Uta Neumann, Oliver Blankenstein, et al.
Clinical Pharmacology and Therapeutics
|
October 17, 2020
Perspectives on Model-Informed Precision Dosing in the Digital Health Era: Challenges, Opportunities, and Recommendations
Franziska Kluwe, Robin Michelet, Anna Mueller-Schoell, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 90) with videos related to
Sort By:
Page
of 9
Frontiers in Cell and Developmental Biology
|
October 17, 2022
Spontaneous transitions between amoeboid and keratocyte-like modes of migration
Ted Moldenhawer, Eduardo Moreno, Daniel Schindler, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
July 27, 2025
Predicting Residual 21-Hydroxylase Enzymatic Activity in Pediatric and Adult Congenital Adrenal Hyperplasia Patients: Towards Individualized Therapy
Davide Bindellini, Robin Michelet, Yersultan Mirasbekov, et al.
Clinical Pharmacokinetics
|
August 2, 2017
Predicting Cortisol Exposure from Paediatric Hydrocortisone Formulation Using a Semi-Mechanistic Pharmacokinetic Model Established in Healthy Adults
Johanna Melin, Zinnia P Parra-Guillen, Niklas Hartung, et al.
The AAPS Journal
|
October 15, 2016
Magnitude of Increased Infliximab Clearance Imposed by Anti-infliximab Antibodies in Crohn's Disease Is Determined by Their Concentration
Helena Edlund, Casper Steenholdt, Mark A Ainsworth, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 14, 2020
Pharmacokinetic/Pharmacodynamic Evaluation of Hydrocortisone Therapy in Pediatric Patients with Congenital Adrenal Hyperplasia
Johanna Melin, Zinnia P Parra-Guillen, Robin Michelet, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
July 7, 2026
Optimizing Clinical Study Designs for CAR-T Cell Therapy: Development of an Efficient Sampling Strategy Through Optimal Experimental Design
Fenja Klima, Anna M Mc Laughlin, Robin Michelet, et al.
Pharmaceutical Statistics
|
April 2, 2019
Comment on Jaki et al., A proposal for a new PhD level curriculum on quantitative methods for drug development. Pharmaceutical Statistics 17 (5):593-606, Sep/Oct 2018, DOI: 10.1002/pst.1873
Andreas Krause, Charlotte Kloft, Wilhelm Huisinga, et al.
The Journal of Antimicrobial Chemotherapy
|
November 13, 2025
The β-lactamase inhibitor concentration-dependent minimum inhibitory concentration (MICcBLI) as methodology to assess the pharmacokinetic/pharmacodynamic relationship of piperacillin/tazobactam for dosing optimization
Malin Andersson, Franz Weber, Ferdinand Weinelt, et al.
Frontiers in Pharmacology
|
April 4, 2022
Exploring Dried Blood Spot Cortisol Concentrations as an Alternative for Monitoring Pediatric Adrenal Insufficiency Patients: A Model-Based Analysis
Viktoria Stachanow, Uta Neumann, Oliver Blankenstein, et al.
Clinical Pharmacology and Therapeutics
|
October 17, 2020
Perspectives on Model-Informed Precision Dosing in the Digital Health Era: Challenges, Opportunities, and Recommendations
Franziska Kluwe, Robin Michelet, Anna Mueller-Schoell, et al.
Page
of 9